Surgery – Liquid medicament atomizer or sprayer
Reexamination Certificate
2006-04-18
2006-04-18
Lewis, Aaron J. (Department: 3743)
Surgery
Liquid medicament atomizer or sprayer
C128S200220, C128S203120, C128S204230
Reexamination Certificate
active
07028686
ABSTRACT:
Dosages of inhaled insulin are controlled within a narrow range by controlling the total volume of air inhaled by a patient. By repeatedly delivering aerosolized insulin with the same total inhaled volume of air, the amount of insulin delivered to the patient each time is consistent. A device for delivering insulin by inhalation is disclosed which device comprises a means for measuring inhaled volume and for halting inhalation at a pre-determined point. The device also comprises an adjustable means for applying various amounts of force to a container of formulation to expel different amounts of drug from the container based on the force applied.
REFERENCES:
patent: 3812854 (1974-05-01), Michaels et al.
patent: 3977394 (1976-08-01), Jones et al.
patent: 3991304 (1976-11-01), Hillsman
patent: 4106503 (1978-08-01), Rosenthal et al.
patent: 4361401 (1982-11-01), Smith et al.
patent: 4604847 (1986-08-01), Moulding, Jr. et al.
patent: 4627432 (1986-12-01), Newell et al.
patent: 4677975 (1987-07-01), Edgar et al.
patent: 4686231 (1987-08-01), Bender et al.
patent: 4796614 (1989-01-01), Nowacki et al.
patent: 4819629 (1989-04-01), Jonson
patent: 4852582 (1989-08-01), Pell
patent: 4877989 (1989-10-01), Drews et al.
patent: 4907581 (1990-03-01), King
patent: 4926852 (1990-05-01), Zoltan et al.
patent: 4984158 (1991-01-01), Hillsman
patent: 5006343 (1991-04-01), Benson et al.
patent: 5011678 (1991-04-01), Wang et al.
patent: 5167506 (1992-12-01), Kilis et al.
patent: 5284133 (1994-02-01), Burns et al.
patent: 5327883 (1994-07-01), Williams et al.
patent: 5363842 (1994-11-01), Mishelevich et al.
patent: 5364838 (1994-11-01), Rubsamen
patent: 5394866 (1995-03-01), Ritson et al.
patent: 5404871 (1995-04-01), Goodman et al.
patent: 5450336 (1995-09-01), Rubsamen et al.
patent: 5497944 (1996-03-01), Weston et al.
patent: 5672581 (1997-09-01), Rubsamen et al.
patent: 5743250 (1998-04-01), Gonda et al.
patent: 5884620 (1999-03-01), Gonda et al.
patent: 5915378 (1999-06-01), Lloyd et al.
patent: 5941240 (1999-08-01), Gonda et al.
patent: 6167880 (2001-01-01), Gonda et al.
patent: 0 232 235 (1987-08-01), None
patent: 0 186 280 (1995-10-01), None
patent: 2 104 393 (1983-03-01), None
patent: 2164569 (1985-07-01), None
patent: 2 164 569 (1985-07-01), None
patent: 2 153 081 (1985-08-01), None
patent: 2164569 (1986-03-01), None
patent: 2 255 918 (1992-11-01), None
patent: 2 256 805 (1992-12-01), None
patent: H03-99667 (1991-04-01), None
patent: H04-100557 (1992-04-01), None
patent: H05-31421 (1993-02-01), None
patent: H05-123399 (1993-05-01), None
patent: WO 92/01815 (1972-09-01), None
patent: WO 90/12814 (1990-11-01), None
patent: WO 90/14468 (1990-11-01), None
patent: WO 91/01868 (1991-02-01), None
patent: WO 92/07599 (1992-05-01), None
patent: WO 92/09322 (1992-06-01), None
patent: WO 92/15353 (1992-09-01), None
patent: WO 93/17728 (1993-09-01), None
Newman et al., “How Should a Pressurized Beta-Adrenergic Bronchodilator be Inhaled?”, 1981, Eur. J. Respir. Dis. 62:3-21.
Newman et al., “How Should a Pressurized Beta Adrenergic Bronchodilator be Inhaled?”, 1981, Eur. J. Respir. Dis. 62, pp. 3-21.
Colthrope, P. et al., (1992), “The pharmacokinetics of pulmonary delivered insulin: a comparison of intratracheal and aerosol administration to the rabbit,”Pharmaceutical Research9:764-8.
Elliott, R.B. et al., (1987), “Parenteral absorption of insulin from the lung in diabetic children.”Aust. Paediatr. J.23:298-297.
Kohler, D., (1990), “Aerosols for systemic treatment.”LungSuppl.:677-84.
Laube, B.L., et al., (1991), “Deposition, clearance, and effects in the lung.”Journal Aerosol Medicine4:286.
Laube, B.L., et al., (1994), “Preliminary Study of the Efficacy of insulin aerosol delivered by oral inhalation in diabetic patients.”JAMA269:2106-2109.
Moses, A.C., et al., (1983), “Insulin administered intranasally as an insulin-bile salt aerosol—effectiveness and reproducibility in normal and diabetic subjects.”Diabetes32:1040-7.
Newman, S.P., et al., (1981), “Deposition of pressurized aerosois in the human respiratory tract.”Thorax.36:52-55.
Newman, S.P., et al., (1981), “How Should a pressurized β-adrenergic bronchodilator be inhaled.”Eur. J. Respir. Dis.62:3-21.
Newman, S.P., et al., (1981) “Deposition of pressurized suspension aerosols inhaled through extension devices.”Am. Rev. Respir. Dis.124:317-320.
Newman, S. P., et al., (1983)Deposition and Effects of Inhalation Aerosols.Royal Free Hospital. London, ISBN-91-86058-03-07.
Remington's Pharmaceutical Sciences, A.R. Gennaro, ed., 1985, Mack Publishing Co.
Salzman, R. (1985) “Intranasal aerosolized insulin mixed-meal studies and long-term use in type 1 diabetes.”New England Journal of Medicine213:1078-84.
Sciarra et al., (1976), “In Vitro Release of Therapeutically Active Ingredients from Polyer Matrixes.”Journal of Pharmaceutical Sciences65(4):1519-1522.
Wigley, F.M., et al., (1971) “Insulin across respiratory mucosae by aerosol delivery.”Diabetes20:552-556.
Yoshida, H., et al., (1979) Absorption of insulin delivered to rabbit trachea using aerosol dosage form.:Journal of Pharmaceutical Science68:670-1.
How Should a Pressurized B-Adrenergic Bronchodilator be Inhaled? (Dec. 1980).
Farr Stephen J.
Gonda Igor
Rubsamen Reid M.
Aradigm Corporation
Bozicevic Karl
Bozicevic Field & Francis LLP
Lewis Aaron J.
LandOfFree
Inhaled insulin dosage control delivery enhanced by... does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Inhaled insulin dosage control delivery enhanced by..., we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Inhaled insulin dosage control delivery enhanced by... will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-3603201